• 1

    Japan Panel Clears Joenja, Dojolvi, Bayer MRI Contrast Agent

  • 2

    Japan Drug Prices to Fall 4% in FY2026 Revision: Official Gazette

  • 3

    Japan Approves MSD’s HIV Combo Idvynso

  • 4

    Japan Hands Out Orphan Tags to Ianalumab, Bleximenib, and Lots More Drugs

  • 5

    Japan Panel to Review Joenja, Dojolvi for Approval at March 5 Session